PIK3CA and cancer: In particular, since this study determined the HLA-restriction and precise epitope sequences in PIK3CA-H1047R or C-Kit-D816V, we will confirm their immunogenicity in T cells from HLA-matched cancer patients with the corresponding mutations in a future study.